Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Advisorshares Pure Cannabis ETF (YOLO)

11.9296   0.23 (1.96%) 11-19 12:22
Open: 11.64 Pre. Close: 11.7
High: 12.0102 Low: 11.63
Volume: 29,536 Market Cap: 0M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 12.134 - 12.201 12.201 - 12.256
Low: 11.474 - 11.568 11.568 - 11.645
Close: 11.562 - 11.701 11.701 - 11.814

Technical analysis

as of: 2019-11-19 12:02:49 PM
Overall:       
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 15.51     One year: 16.70
Support: Support1: 11.63    Support2: 9.68
Resistance: Resistance1: 13.28    Resistance2: 14.30
Pivot: 12.86
Moving Average: MA(5): 12.04     MA(20): 13.12
MA(100): 17.34     MA(250):
MACD: MACD(12,26): -0.69     Signal(9): -0.62
Stochastic oscillator: %K(14,3): 9.08     %D(3): 8.82
RSI: RSI(14): 30.31
52-week: High: 26.50  Low: 0.26  Change(%): 4393.2
Average Vol(K): 3-Month: 5132  10-Days: 5831

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
YOLO has closed above bottom band by 11.9%. Bollinger Bands are 6.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2019-11-15
The Week In Cannabis: Stocks Fall On Poor Earnings, More Americans Support Legalization
Two-thirds of Americans say the use of marijuana should be legal, reflecting a considerable surge over the past decade.. Two-thirds of Americans say the use of marijuana should be legal, reflecting a steady increase over the past decade https://t.co/QoMXjiaUYk pic.twitter.com/V4vLqY3r9f — Pew Research Fact Tank (@FactTank) November 14, 2019 GW Pharmaceuticals PLC (NASDAQ: GWPH ) announced two of its medicines have been recommended by the U.K.’s National Institute for Health and Care Excellence to receive routine reimbursement from the National Health Service. Epidiolex, known as Epidyolex in Europe, and Sativex were approved by the NHS for the treatment of epilepsy and multiple sclerosis, respectively. These were probably the most upbeat news items in the cannabis and hemp world this week. The following companies disappointed analysts and investors with their quarterly results and/or guidance (see full coverage for all of these earnings reports in our Cannabis Earnings Portal ): Canopy Growth Corp (NYSE: CGC ) Neptune Wellness Solutions Inc.

2019-10-27
The Week In Cannabis: Hexo Postpones Q4 Report, Rapinoe Teams With CBD Brand, Sanders Unveils Legalization Plan
Business, finance and policy leaders from around the globe convened this week in Chicago for the Benzinga Cannabis Capital Conference to hear from the main voices in the space, from Bruce Linton, executive chairman of Gage Cannabis, and Jessica Billingsley, CEO of Akerna Corp (NASDAQ: KERN ), to Tim Seymour, Jon Najarian and Jim Belushi. The corporate world continued to suffer, as more big public companies continued to put out bad news, including HEXO Corp (NYSE: HEXO ) postponing its fourth-quarter report and announcing considerable layoffs — and at the same time launching a $70 million private placement. Firings in the industry this year stand at around 600, according to Business Insider's Jeremy Berke . “It's been another difficult week for cannabis companies. The combination of Zenabis Global Inc (OTC: ZBISF ) and Hexo both delivering disappointing news to the industry continues to keep the pressure on stock prices,” Debra Borchartd, CEO of Green Market Report, told Benzinga. “Zenabis announced a rights offering that sparked a torrent of accusations about shorting, while Hexo delayed its earnings announcement and said it would layoff 200 employees.

Financial Analysis

Growth NA
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability NA
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency NA
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange: 
Sector: 
Industry: 
Shares Out. (M)
Shares Float (M)
% Held by Insiders
% Held by Institutions
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS
Book Value (p.s.)
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm)
Return on Equity (ttm)
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M)
Levered Free Cash Flow (M)

Stock Valuations

P/E
P/E Growth Ratio
P/BV
P/S -10000000000.00
P/CF

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.